Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection

Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection

<p>HCV infects 170 million persons worldwide and is a serious global health problem. Genotype-3a is the dominant genotype in newly diagnosed infections within the UK and has a high response rate to interferon therapy, with up to 70% patients achieving a sustained virological response (SVR). Th...

Descripció completa

Dades bibliogràfiques
Autors principals:	Humphreys, I, Isla S. Humphreys
Altres autors:	Barnes, E
Format:	Thesis
Idioma:	English
Publicat:	2011
Matèries:	Infectious diseases Biology (medical sciences) Immunology

Ítems similars

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
per: Hennig, B, et al.
Publicat: (2008)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
per: Antrobus, R
Publicat: (2014)

Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
per: Gupta, P
Publicat: (2014)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
per: Kelly, C
Publicat: (2013)

Aspects to T-cell phenotype during infection with HIV, CMV and Hepatitis C virus
per: Northfield, J
Publicat: (2008)

Contribution of monocytes to immunopathology during influenza A virus infection
per: Cole, S, et al.
Publicat: (2014)

Functional impact of CD161 on T cells
per: Smith, K
Publicat: (2013)

B cell and antibody responses to influenza a virus in human
per: Huang, K
Publicat: (2011)

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
per: Satomi Ando, et al.
Publicat: (2023-01-01)

The role of the cytoplasmic domain of the macrophage scavenger receptor MARCO in adhesion and uptake
per: Kroos, M
Publicat: (2008)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
per: Ronan, E
Publicat: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
per: Griffiths, K
Publicat: (2012)

HLA-B51 associated HIV-1 viral control
per: Peng, Y
Publicat: (2013)

The role of T cell immunity in natural influenza A infection in a UK cohort: flu watch
per: Wang, L
Publicat: (2014)

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile
per: Eyre, D, et al.
Publicat: (2013)

Implications of HCV genotype 3 specific immunity on cross-reactive vaccine design
per: von Delft, A, et al.
Publicat: (2014)

Dynamics of co-infection in fish: A review of pathogen-host interaction and clinical outcome
per: Ekemini Moses Okon, et al.
Publicat: (2023-12-01)

Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon
per: Clauvis Kunkeng Yengo, et al.
Publicat: (2020-10-01)

Liver-stage vaccines for malaria
per: Longley, RJ
Publicat: (2013)

Function, phenotype and development of human CD161+CD8 T cells
per: Walker, LJ
Publicat: (2012)

Memory T cell responses in influenza A infection and vaccination in humans
per: Chui, C
Publicat: (2012)

NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice
per: Ha-Na Lee, et al.
Publicat: (2022-02-01)

Human papillomavirus type 16 and 18 viral loads as predictors associated with abnormal cervical cytology among women in Saudi Arabia
per: D.A. Obeid, et al.
Publicat: (2020-02-01)

Hepatitis B vaccination
per: Pollard, A
Publicat: (2007)

Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth
per: Youchao Dai, et al.
Publicat: (2023-04-01)

IRGM1 supports host defense against intracellular bacteria through suppression of type I interferon in mice
per: Prashant Rai, et al.
Publicat: (2023-11-01)

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
per: Simone A. Thair, et al.
Publicat: (2021-01-01)

A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion
per: Horton, Brendan, et al.
Publicat: (2020)

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells
per: Shirin Nkongolo, et al.
Publicat: (2023-01-01)

Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses
per: Laura K. Aisenberg, et al.
Publicat: (2022-06-01)

Immunopathogenic CSF TCR repertoire signatures in virus-associated neurologic disease
per: Satoshi Nozuma, et al.
Publicat: (2021-02-01)

Characterisation of expression and function of respiratory epithelial CD1d
per: Hajipouran Benam, K
Publicat: (2014)

Potently neutralizing human mAbs against the zoonotic pararubulavirus Sosuga virus
per: Helen M. Parrington, et al.
Publicat: (2023-04-01)

Characterisation of the immune response to PARV4
per: Simmons, RA
Publicat: (2011)

Protocol for influenza A virus infection of mice and viral load determination
per: Ioanna-Evdokia Galani, et al.
Publicat: (2022-03-01)

Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches
per: Pearson, FE
Publicat: (2011)

Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection
per: Kai Deng, et al.
Publicat: (2023-04-01)

Basophil-derived IL-4 promotes cutaneous Staphylococcus aureus infection
per: Juan-Manuel Leyva-Castillo, et al.
Publicat: (2021-11-01)

Ebola virus protein VP40 stimulates IL-12– and IL-18–dependent activation of human natural killer cells
per: Hung Le, et al.
Publicat: (2022-08-01)

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
per: McNaughton, AL, et al.
Publicat: (2022)